Avita Therapeutics Inc.

(RCEL) Trade

By |

Profile

Avita Therapeutics is a single product company, the RECELL system, an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes thus avoiding or reducing the need for skin grafts. The device is approved for the treatment of adult patients in the U.S. with paediatric clinical trials and expanded indications in soft tissue wounds and vitiligo underway. It is currently in roll-out across the approximately 132 burn centres in the U.S. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories. It is expected to gain approval and launch in Japan via distribution partner Cosmotec shortly.

Contact Information

Website: www.avitamedical.com
Main Phone: +1 661 367-9170
Address: 28159 Avenue Stanford
Address 2: Suite 220, Valencia
State: CA
City / Town: Los Angeles
Country: US
Postal Code: 91355

Issuer Information

Exchange: NSC
CEO: Michael S. Perry
Employees: 98
NAICS: Surgical and Medical Instrument Manufacturing(339112)

Equities News

Profile

Avita Therapeutics is a single product company, the RECELL system, an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes thus avoiding or reducing the need for skin grafts. The device is approved for the treatment of adult patients in the U.S. with paediatric clinical trials and expanded indications in soft tissue wounds and vitiligo underway. It is currently in roll-out across the approximately 132 burn centres in the U.S. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories. It is expected to gain approval and launch in Japan via distribution partner Cosmotec shortly.

Contact Information

Website: www.avitamedical.com
Main Phone: +1 661 367-9170
Address: 28159 Avenue Stanford
Address 2: Suite 220, Valencia
State: CA
City / Town: Los Angeles
Country: US
Postal Code: 91355

Issuer Information

Exchange: NSC
CEO: Michael S. Perry
Employees: 98
NAICS: Surgical and Medical Instrument Manufacturing(339112)

Equities News

$ 22.95 $ 1.46 (6.79%)
Last Price 22.95 Change $ 1.46 Change % 6.79 Tick N/A
Bid 23.70 Bid Size 3,900.00 Ask 26.00 Ask Size 100.00
Open 22.95 High 23.31 Low 22.18 Prev Close 21.49
Last Trade Volume 228,243 52 Wk Hi 30.79 52 Wk Low 16.88
Market Cap 496.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 21,628,633.00 EPS (TTM) 17.01 PE Ratio 1.30 Exchange NCM
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 4 4 4 4
Low Target Price Estimate 4 4 4 4
Mean Target Price Estimate 4 4 4 4
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 08/22/16 08/22/16 08/22/16 08/22/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 0 0 0
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 0 0 0